NCT06205771View on ClinicalTrials.gov

The Role and Mechanism of GPER-Hippo-CBS/H2S Pathway in Preeclampsia

NAEnrolling by invitationINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

October 31, 2029

Study Completion Date

December 31, 2029

Conditions

Preeclampsia

Interventions

OTHER

H2S content

H2S content

Trial Locations (1)

250000

The First Affiliated Hospital of Shandong First Medical University &Shandong Provincial Qianfoshan Hospital, Jinan

All Listed Sponsors

lead

Hao Feng

OTHER